Please see full Important Safety Information below in the pinned post and at Calquencehcp.com/#isi. This product information is intended for US Healthcare Professionals only.
CALQUENCE is a registered trademark of AstraZeneca. It is not associated with any individual users on LinkedIn.
Please see full Prescribing Information, including Patient Information, by visiting https://qr.short.az/CalquenceISI.
You may report side effects related to AstraZeneca products by visiting https://us-aereporting.astrazeneca.com/adverse-events.html.
US-99288 Last Updated 4/25
Company Details
- Industry
- Pharmaceutical Manufacturing
- NAICS
-
Pharmaceutical and Medicine ManufacturingMedicinal and Botanical ManufacturingPharmaceutical Preparation ManufacturingIn-Vitro Diagnostic Substance ManufacturingBiological Product (except Diagnostic) Manufacturing
- Website
- https://calquencehcp.com
- Keywords
- Representative jobs.
Calquence® (Acalabrutinib) Hcp Questions
Calquence® (Acalabrutinib) Hcp's website is https://calquencehcp.com
Calquence® (Acalabrutinib) Hcp's LinkedIn profile is https://www.linkedin.com/company/calquencehcp
Calquence® (Acalabrutinib) Hcp's industry is
Pharmaceutical Manufacturing
Calquence® (Acalabrutinib) Hcp's top competitors are
Lynparza®(Olaparib) Hcp,
Astrazeneca,
Tezspire® (Tezepelumab-Ekko) Hcp,
Cardinal Health,
Shockwave Medical,
Abbvie,
Opdivo® (Nivolumab) Us Hcp,
Parexel,
Vabysmoⓡ (Faricimab-Svoa),
Johnson & Johnson.
Calquence® (Acalabrutinib) Hcp's categories are Pharmaceutical Manufacturing
